Welcome!
Восстановление пароля
Введите адрес электронной почты или телефон, указанные при регистрации. Вам будет отправлена инструкция по восстановлению пароля.
Некорректный формат электронной почты или телефона
Гербердинг Джули
Julie Gerberding
Executive Vice President, Strategic Communications, Global Public Policy and Population Health, Chief Patient Officer, MSD
Quotes
07.06.2019
SPIEF 2019
Life Course Immunization: Investing in the Future
Creating an innovative vaccine is a primary problem. The number of companies involved in it is going down every year, because business and vaccine production is stable, while its economics and marketing are too complicated – especially when it comes to small companies – to stay profitable, keep their market position and survive
07.06.2019
SPIEF 2019
Life Course Immunization: Investing in the Future
Even if we have a good and reliable product, we are not always able to persuade people in some countries that it is a must, because they do not want to do it
07.06.2019
SPIEF 2019
Life Course Immunization: Investing in the Future
We need to work on this together: leaders, managers of healthcare facilities, and schools – people need to be educated
07.06.2019
SPIEF 2019
The Architecture of Public Health: International Experience and National Priorities
Good public health is good for business, and good business is good for public health. We have in the private sector both an opportunity and a responsibility to contribute to the health of our employees
06.06.2019
SPIEF 2019
Healthcare Transformation: How Will Modern Technologies Change Lives?
One will be able to control and monitor their health, and this is how diseases will be diagnosed sooner. This is developing really fast
06.06.2019
SPIEF 2019
Healthcare Transformation: How Will Modern Technologies Change Lives?
There are issues that cannot be resolved single-handedly. They require cooperating with the government that must make decisions on prioritizing and supporting fundamental research